Sofosbuvir-Velpatasvir

Generic Name: Sofosbuvir/Velpatasvir

Brand Names: Epclusa

Epclusa is a pan-genotypic hepatitis C treatment that cures most patients in 12 weeks.

AntiviralHepatitis

What It's Used For

Sofosbuvir-velpatasvir is prescribed for:

Chronic hepatitis C infection (all genotypes)
With or without cirrhosis
Gastrointestinal liver disease

Pan-genotypic - works against all HCV genotypes.

Side Effects

Common side effects:

Headache
Fatigue
Nausea
Insomnia

Serious side effects:

Hepatitis B reactivation (test before treatment)
Bradycardia with amiodarone

Additional Information

What is Sofosbuvir-Velpatasvir?

This combination is a direct-acting antiviral regimen that cures hepatitis C in over 95% of patients.

Revolutionary Treatment

Hepatitis C is now curable with 12 weeks of oral medication - a medical breakthrough.

Hepatitis B Screening

Must screen for hepatitis B before starting, as reactivation can occur.

For details, see MedlinePlus.

Related Health Conditions

This medication is commonly used to treat or manage the following conditions:

Cirrhosis

Cirrhosis is irreversible, late-stage liver disease where scar tissue replaces healthy tissue, impairing its vital functions like filtering toxins and often caused by alcohol abuse or hepatitis.

Learn More

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.

Loading questions...

Ask Dr. Zimmer

Have questions about Sofosbuvir-Velpatasvir? Get expert answers from Dr. Zimmer.

Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.

Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.

Menu